Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
This quick comparison explains why price indices and total return indices diverge, focusing on dividends and reinvestment effects.
28,657 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
A half-century-old rule for scaling software teams is breaking as AI fueled capital changes how firms grow. Investors...
As inflation cools and rates hold, retirees are increasingly turning to preferred stock ETFs to secure steady, bond-l...
Analysts are revising upward expectations for the Q2 earnings season, driven by energy and technology strength, a rar...
A volatile session followed reports of tanker attacks in the Persian Gulf, with the VIX surging and oil prices pushin...
U.S. stock indexes pushed higher Friday, extending gains as AI leaders and mega-cap tech names drive valuations highe...
With San Francisco home prices and daily expenses on the rise, investors are eyeing a dividend portfolio that cover l...
A hypothetical scenario examines how a presidential message could ripple markets, driving oil spikes, safe-haven trad...
A leading crypto analyst says XRP has hit a critical RSI threshold, with the two-month reading near 50 as price sits ...
A morgan stanley portfolio manager says the market isn’t sliding toward another dot-com frenzy, despite a wave of AI-...
In early 2026, retirees are increasingly adopting a low-volatility ETF to stabilize portfolios amid ongoing market vo...
The Roundhill Bitcoin Covered Call ETF uses a synthetic options strategy to generate income from Bitcoin exposure wit...